SCHEMBL6511445

SCHEMBL6511445

Cc1ccc(S(=O)(=O)OCC2Cn3c(nc4c(C)cccc43)-c3cccc(Cl)c3O2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.38
CYP3A4 P08684 2/20 0.38
CYP2D6 P10635 2/20 0.38
TSHR P16473 2/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
MAPT P10636 1/20 0.38
MAPK1 P28482 1/20 0.38
GRM2 Q14416 4/20 0.34
KDM4E B2RXH2 1/20 0.32
HPGD P15428 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
GRM5 P41594 1/20 0.31
TP53 P04637 1/20 0.31
VDR P11473 1/20 0.31
HTR6 P50406 1/20 0.30
SMN1; SMN2 Q16637 2/20 0.30
NPC1 O15118 1/20 0.30
LMNA P02545 1/20 0.30
NR2F2 P24468 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6515650 0.75 PTGS2 (0.42) ALDH1A1CYP3A4CYP2D6TSHRCYP2C9
SCHEMBL6519028 0.74 HTR3A (0.34) MAPTNPC1RAB9A
SCHEMBL3207601 0.73 ALDH1A1 (0.40) ALDH1A1CYP3A4CYP2D6TSHRCYP2C9
SCHEMBL9446303 0.72 ALDH1A1 (0.39) ALDH1A1CYP3A4CYP2D6TSHRCYP2C9
SCHEMBL6971095 0.70 CA2 (0.54) ALDH1A1CYP3A4CYP2D6TSHRCYP2C9
SCHEMBL6971100 0.70 CA2 (0.54) ALDH1A1CYP3A4CYP2D6TSHRCYP2C9
SCHEMBL4224731 0.70 ALDH1A1 (0.39) ALDH1A1CYP3A4CYP2D6TSHRCYP2C9
SCHEMBL4220212 0.70 AQP1 (0.41) ALDH1A1CYP3A4CYP2D6TSHRCYP2C9
SCHEMBL4621704 0.69 CA2 (0.43) ALDH1A1CYP3A4CYP2D6TSHRCYP2C9
SCHEMBL4621993 0.69 CA2 (0.43) ALDH1A1CYP3A4CYP2D6TSHRCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050239767-A1 Intermolecular SNAr of the heterocycle-activated nitro and fluoro groups-application in the synthesis of polyazamacrocyclic ligands NATIONAL SCIENCE FOUNDATION 2005-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050239767-A1 Intermolecular SNAr of the heterocycle-activated nitro and fluoro groups-application in the synthesis of polyazamacrocyclic ligands TECR, PAICS, DCXR ALDH1A1 1812/4885CYP3A4 51/4885CYP2D6 852/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.